4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-059947
Director sold 20,054 shares at $10.63 ($213,144)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Borgeson Blake · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-26 | Sale : show line 1 in the form 10b5-1 | −20,054 | $10.63 | $213,144 | 7,364,472 | D |
| Open-market sales · 20,054 sh · avg $10.63 · $213,144 | ||||||
Loading xslF345X05/doc4.xml…